ArticleScientific reports2026
A national cross-sectional study of patients with inherited retinal disease in China.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
To address the lack of comprehensive data on the health and living status of Chinese patients with inherited retinal diseases (IRDs). A questionnaire survey was conducted among 2218 IRD patients or their proxies, with data analyzed across six key dimensions: general features, family status, symptoms, diagnosis and treatment, rehabilitation, and life impact. The patients had a male-to-female ratio of ~ 6:4, mean age of 28.51 ± 17.14 years, 32.42% with disability certificates, and 27.68% of adults unemployed. Most (77.68%) had a per capita annual household income ≤ RMB 100,000. The mean age of onset was 13.11 years, with 50.09% reporting disease progression turning points (e.g., COVID-19, overwork). The average time from onset to diagnosis was 5.87 years, 42.47% experienced misdiagnosis, 33.81% received treatment (70.27% dissatisfied with effects), and economic capacity for treatment was limited but improved with long-term installments. Patients showed high willingness for rehabilitation but low acceptance of cross-city training; 45.27% used assistive devices, and 74.39% could travel independently, though IRDs severely impacted daily life. Chinese IRD patients face poor health and living conditions, including delayed diagnosis, high misdiagnosis, low treatment satisfaction, and economic constraints. Comprehensive social security policies are urgently needed to meet their multi-dimensional needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.